Literature DB >> 33153932

Prevalence, types and possible factors influencing mosaicism in IVF blastocysts: results from a single setting.

Lluc Coll1, Mònica Parriego2, Sílvia Mateo2, Sílvia García-Monclús2, Ignacio Rodríguez2, Montserrat Boada2, Buenaventura Coroleu2, Nikolaos P Polyzos2, Francesca Vidal3, Anna Veiga4.   

Abstract

RESEARCH QUESTION: Are intrinsic or extrinsic factors associated with embryo mosaicism prevalence in IVF cycles?
DESIGN: Retrospective cohort study of preimplantation genetic testing for aneuploidy (PGT-A) cycles carried out at a university-affiliated IVF clinic between October 2017 and October 2019. Trophectoderm biopsies were analysed by next generation sequencing. Mosaicism prevalence, type of anomaly and the chromosomes involved were analysed. Intrinsic and extrinsic factors potentially inducing mosaicism were studied: maternal and paternal age, antral follicle count, cumulus-oocyte complexes retrieved, female body mass index, PGT-A indication, sperm concentration, total dosage of gonadotrophins, embryo quality and day of blastocyst formation, single-step commercial media used and biopsy operator.
RESULTS: Overall prevalence of mosaicism in our PGT-A setting was 13.9%. In segmental mosaicism, larger chromosomes tended to be more affected, which was not observed in whole-chromosome mosaicism. Additionally, segmental mosaicism was mostly observed in monosomy (69.6%; P < 0.01) compared with whole-chromosome mosaicism (49.7% monosomies versus 50.3% trisomies; P = 0.83). Although a high inter-patient variability was observed, only paternal age showed a positive association with mosaicism (adjusted OR 1.26, 95% CI 1.02 to 1.54) among the analysed variables.
CONCLUSIONS: Our results suggest remarkable differences in the mechanisms generating segmental and whole-chromosome mosaicism, indicating that they may deserve different consideration when studying them and when prioritizing them for transfer. Male factor seems to be associated with mosaicism and may be worthy of specific assessment in future studies.
Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biopsy; Blastocyst; Mosaicism; PGT-A

Year:  2020        PMID: 33153932     DOI: 10.1016/j.rbmo.2020.09.025

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

1.  To mask or not to mask mosaicism? The impact of reporting embryo mosaicism on reproductive potential.

Authors:  A Armstrong; J Miller; M Quinn; A V Nguyen; L Kwan; L Kroener
Journal:  J Assist Reprod Genet       Date:  2022-07-20       Impact factor: 3.357

2.  The effect of trophectoderm biopsy technique and sample handling on artefactual mosaicism.

Authors:  Lluc Coll; Mònica Parriego; Beatriz Carrasco; Ignacio Rodríguez; Montserrat Boada; Buenaventura Coroleu; Nikolaos P Polyzos; Francesca Vidal; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2022-03-16       Impact factor: 3.357

3.  Evidence-based clinical prioritization of embryos with mosaic results: a systematic review and meta-analysis.

Authors:  Ali Mourad; Roland Antaki; François Bissonnette; Obey Al Baini; Boutros Saadeh; Wael Jamal
Journal:  J Assist Reprod Genet       Date:  2021-09-02       Impact factor: 3.412

4.  Preimplantation genetic testing for aneuploidy: The management of mosaic embryos.

Authors:  Eun Jeong Yu; Min Jee Kim; Eun A Park; Inn Soo Kang
Journal:  Clin Exp Reprod Med       Date:  2022-08-31

Review 5.  Biological and Clinical Significance of Mosaicism in Human Preimplantation Embryos.

Authors:  Ioanna Bouba; Elissavet Hatzi; Paris Ladias; Prodromos Sakaloglou; Charilaos Kostoulas; Ioannis Georgiou
Journal:  J Dev Biol       Date:  2021-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.